Welcome to our dedicated page for Reliance Global Group news (Ticker: EZRA), a resource for investors and traders seeking the latest updates and insights on Reliance Global Group stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Reliance Global Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Reliance Global Group's position in the market.
Reliance Global Group (Nasdaq: EZRA) funded the next milestone in its strategic investment in Enquantum, increasing its ownership by 4% to ~12% fully diluted and securing an additional board seat. The tranche-based agreement can increase Reliance to a 51% fully diluted controlling interest when all milestones complete or if Reliance accelerates funding.
Enquantum is advancing NIST-aligned, hardware-accelerated post-quantum cryptography for high-throughput environments and is engaging prospective partners in North America and planned implementations in southern Israel under the Scale51 commercialization plan.
Reliance Global Group (NASDAQ: EZRA) reported 2025 results and launched EZRA International Group to execute its Scale51 technology expansion strategy. The company closed an investment in Enquantum Ltd. with a pathway to majority control, signed a non-binding term sheet for Scentech Medical, completed divestitures to cut debt, and improved key balance sheet metrics.
2025 highlights: unrestricted cash ~$1.3M (+250%), working capital ~$1.9M (+351%), stockholders’ equity ~$6.4M (+114%), commission income $12.4M, net loss improved to $7.0M.
Reliance Global Group (NASDAQ: EZRA) will host a conference call on March 10, 2026 at 4:30 PM Eastern to discuss fourth quarter 2025 financial results and provide a business update. The call is available by telephone and webcast; replays will be accessible online and by telephone for specified windows.
Telephone access codes and webcast links are provided for live participation and replay through March 10, 2027 (webcast) and March 24, 2026 (telephone replay).
Reliance Global Group (Nasdaq: EZRA) closed its strategic acquisition of Enquantum Ltd. on Feb 23, 2026, starting a milestone-driven path toward a 51% fully diluted controlling interest.
Enquantum develops hardware-accelerated, NIST-aligned post-quantum encryption for terabit-scale environments and holds a 2025 patent for FPGA-based quantum-resistant communications.
Reliance Global Group (Nasdaq: EZRA) signed a definitive agreement to acquire a 51% controlling interest in post-quantum cybersecurity company Enquantum, with an aggregate purchase price of $2,125,000 payable over ~10 months via milestone-tied tranches.
The deal implies a $2,041,667 pre-money valuation and $9.8018 per-share purchase price; initial close yields an 8% fully diluted stake (including conversion of a $166,000 bridge note). Closing expected within 30 days and remains subject to customary conditions.
Reliance Global Group (Nasdaq: EZRA) launched Scale51, an operating and acquisition model within new subsidiary EZRA International Group to acquire controlling 51% stakes in technology companies and scale them in the U.S.
Target sectors include AI/data analytics, cybersecurity, FinTech/InsurTech, and MedTech; potential early transactions with Enquantum and Scentech remain subject to diligence and definitive agreements.
Reliance Global Group (Nasdaq: EZRA) reported a 36% year-over-year increase in Personal Lines Property & Casualty written premium generated through RELI Exchange, rising from approximately $11.47 million in 2024 to approximately $15.6 million in 2025. Growth is attributed to an expanded agency partner network.
Since acquiring RELI Exchange in 2022, the company says its network grew from ~65 to ~300 agency partners, with expansion described as organic rather than acquisition-driven. The written premium figures are internal, unaudited, and presented as an operating metric not equivalent to GAAP revenue.
Reliance Global Group (Nasdaq: EZRA) reported a 72% increase in health insurance policies written through its RELI Exchange during the 2025 open enrollment period. Policies rose to approximately 3,873 in 2025 from 2,258 in 2024.
The company also expanded its broker network from approximately 65 agency partners at acquisition in 2022 to approximately 300 partners, and said RELI Exchange cash flow supports its EZRA International Group acquisition strategy.
Reliance Global Group (Nasdaq: EZRA) reported a 72% year-over-year increase in health insurance policies written through RELI Exchange during the 2025 open enrollment period, rising to approximately 3,873 policies from 2,258 in 2024. The company attributes growth to deeper carrier relationships and improved execution.
Since acquiring RELI Exchange in 2022, the broker network expanded from ~65 to ~300 agency partners, supporting higher policy volumes and helping fund the company’s broader strategic initiatives under EZRA International Group, including planned controlling investments in diagnostic and post-quantum cybersecurity firms.
Reliance Global Group (Nasdaq: EZRA) closed a public offering on January 29, 2026, raising approximately $2.0 million in gross proceeds.
The offering sold 7,407,408 common shares (or pre-funded warrants) and warrants to buy 14,814,816 shares at a combined public price of $0.27 per share.
The warrants are exercisable upon issuance, expire in two years, and H.C. Wainwright acted as exclusive placement agent. Net proceeds are intended for working capital, M&A strategies and general corporate purposes.